October 27th, 2014
•A novel methodology that is employed for the treatment of recurrent glioblastomas is described. This treatment approach employs the application of alternating electric tumor treating fields (TTFields), known as TTF Therapy in combination with bevacizumab, a targeted agent that is currently FDA approved as monotherapy.
Tags
Related Videos
Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
Microscopic Cyst Resection for the Treatment of Patients Diagnosed with Epididymal Cyst
Tuina in a Frozen Shoulder Rat Model: An Efficient and Reproducible Protocol
Ear Plaster Therapy as a Safe and Effective Treatment for Gestational Vomiting
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved